Inge Marie Svane

Inge Marie Svane

Clinical Professor

Member of:

  • Clinical Oncology

ORCID: 0000-0002-9451-6037

Publication year:
All
21 - 30 out of 272Page size: 10
  1. 2023
  2. Published

    TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy

    Tvingsholm, S. A., Frej, M. S., Rafa, V. M., Hansen, U. K., Ormhøj, M., Tyron, A., Jensen, A. W. P., Kadivar, M., Bentzen, A. K., Munk, K. K., Aasbjerg, G. N., Ternander, J. S. H., Heeke, C., Tamhane, T., Schmess, C., Funt, S. A., Kjeldsen, J. W., Kverneland, A. H., Met, Ö., Draghi, A. & 4 others, Jakobsen, S. N., Donia, M., Svane, Inge Marie & Hadrup, S. R., 2023, In: Journal for ImmunoTherapy of Cancer. 11, 8, 16 p., e006847.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    TIL Therapy: Facts and Hopes

    Monberg, Tine Juul, Borch, T. H., Svane, Inge Marie & Donia, M., 2023, In: Clinical Cancer Research. 29, 17, p. 3275-3283 9 p.

    Research output: Contribution to journal › Review › Research › peer-review

  4. Published

    Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy

    Dolton, G., Rius, C., Wall, A., Szomolay, B., Bianchi, V., Galloway, S. A. E., Hasan, M. S., Morin, T., Caillaud, M. E., Thomas, H. L., Theaker, S., Tan, L. R., Fuller, A., Topley, K., Legut, M., Attaf, M., Hopkins, J. R., Behiry, E., Zabkiewicz, J., Alvares, C. & 13 others, Lloyd, A., Rogers, A., Henley, P., Fegan, C., Ottmann, O., Man, S., Crowther, M. D., Donia, M., Svane, Inge Marie, Cole, D. K., Brown, P. E., Rizkallah, P. & Sewell, A. K., 2023, In: Cell. 186, 16, p. 3333-3349.e27 45 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Accepted/In press

    “One more chance to survive”: the experiences of patients with advanced melanoma and their partners with tumor-infiltrating lymphocyte therapy—a qualitative study and recommendations for future care

    Egeler, M. D., Boomstra, E., Rohaan, M. W., Van den Heuvel, N. M. J., Fraterman, I., Delfos, M., van de Poll-Franse, L. V., Borch, T. H., Svane, Inge Marie, Haanen, J. B. A. G., Retèl, V. P. & Boekhout, A. H., 2023, (Accepted/In press) In: Journal of Cancer Survivorship.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. 2022
  7. Published

    Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma

    Mork, S. K., Kadivar, M., Bol, K. F., Draghi, A., Westergaard, M. C. W., Skadborg, S. K., Overgaard, N., Sorensen, A. B., Rasmussen, I. S., Andreasen, L. V., Yde, C. W., Trolle, T., Garde, C., Friis-Nielsen, J., Norgaard, N., Christensen, D., Kringelum, J. V., dqp123, dqp123, Hadrup, S. R. & Svane, Inge Marie, 31 Dec 2022, In: OncoImmunology. 11, 1, 15 p., 2023255.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Immune checkpoint inhibitor treatment and ophthalmologist consultations in patients with malignant melanoma or lung cancer—A nationwide cohort study

    D’Souza, M., Bagger, M., Alberti, M., Malmborg, M., Schou, Morten, Torp-Pedersen, Christian, Gislason, Gunnar Hilmar, Svane, Inge Marie & Kiilgaard, Jens Folke, 1 Jan 2022, In: Cancers. 14, 1, 13 p., 49.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV

    Klausen, U., Grauslund, J. H., Jørgensen, N. G. D., Ahmad, S. M., Jonassen, M., Weis-Banke, S. E., Martinenaite, E., Pedersen, L. B., Lisle, T. L., Gang, Anne Ortved, Enggaard, L., Hansen, M., Holmström, M. O., Met, Özcan, Svane, Inge Marie, Niemann, Carsten, Pedersen, Lars Møller & Andersen, Mads Hald, 2022, In: Frontiers in Oncology. 12, 1023015.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors – A phase I trial

    Lorentzen, C. L., Martinenaite, E., Kjeldsen, J. W., Holmstroem, R. B., Mørk, S. K., Pedersen, A. W., Ehrnrooth, E., Andersen, Mads Hald & Svane, Inge Marie, 2022, In: Frontiers in Immunology. 13, 1023023.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells

    Weis-Banke, S. E., Lisle, T. L., Perez Penco, Maria, Schina, A., Hübbe, M. L., Siersbæk, M., Holmström, M. O., Jørgensen, M. A., Svane, Inge Marie, Met, Özcan, Ødum, Niels, Madsen, Daniel Hargbøl, dqp123, dqp123, Grøntved, L. & Andersen, Mads Hald, 2022, In: Journal for ImmunoTherapy of Cancer. 10, 10, e005326.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    B Cells and Tertiary Lymphoid Structures: Friends or Foes in Cancer Immunotherapy?

    Lauss, M., dqp123, dqp123, Svane, Inge Marie & Jönsson, G., 2022, In: Clinical Cancer Research. 28, 9, p. 1751–1758 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...28 Next

ID: 4054758